Keratoacanthoma: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 31: | Line 31: | ||
{{stub}} | {{stub}} | ||
== Keratoacanthoma == | |||
<gallery> | |||
File:Generalized_eruptive_keratoacanthomas_of_Grzybowski.jpg|Generalized eruptive keratoacanthomas of Grzybowski | |||
File:Skin_keratoacanthoma_whole_slide.jpg|Skin keratoacanthoma whole slide | |||
</gallery> | |||
Revision as of 02:04, 18 February 2025
Keratoacanthoma (KA) is a common low-grade (unlikely to metastasize or spread to other parts of the body) skin tumour that is derived from cells of the hair follicle. KAs are characterized by rapid growth over a few weeks to months, followed by spontaneous resolution over 4 to 6 months in most cases.
Epidemiology
Keratoacanthomas occur more frequently in light-skinned individuals, particularly those with a history of prolonged sun exposure. The incidence increases with age, and it is rare in children and uncommon in adults under 30 years.
Pathogenesis
The exact cause of keratoacanthoma is unknown, but it is believed to be associated with exposure to ultraviolet light. Other potential risk factors include immunosuppression, chemical carcinogens, and genetic predisposition.
Clinical Presentation
Keratoacanthomas typically present as a solitary, rapidly growing, dome-shaped nodule with a central keratin-filled crater. They most commonly occur on sun-exposed areas of the body, particularly the face and hands.
Diagnosis
The diagnosis of keratoacanthoma is primarily clinical, based on the characteristic appearance and rapid growth of the lesion. Biopsy may be performed to confirm the diagnosis and rule out more serious conditions, such as squamous cell carcinoma.
Treatment
Treatment options for keratoacanthoma include surgical excision, cryotherapy, and topical chemotherapy. In some cases, no treatment is necessary as the lesion may resolve spontaneously.
Prognosis
The prognosis for keratoacanthoma is generally good, as most lesions resolve spontaneously and rarely metastasize. However, recurrence is common, particularly in individuals with a history of multiple lesions.


